Summary
- evitria productions show consistent glycan profiles between batches. These profiles are in agreement with commercially available (GMP) antibodies.
- Glycan analysis by LC-MS can verify glycan modifications, such as afucosylation, to provide further quality assurance.
- The production of high quality, reproducible material is critical for the development of antibody-based therapeutics. The evitria-Genovis workflow combines rapid, high quality, antibody production with high-throughput mass spectrometry for greater insight and control of key quality attributes.
